E Mingyan

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0001-5127-6400

发表论文 50 篇 · 总被引 624 次 · h-index 13

代表论文

• Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis (2024 · Advanced Science · 被引 108)
• PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies (2021 · Frontiers in Immunology · 被引 58)
• Novel small molecule inhibitors of the transcription factor ETS-1 and their antitumor activity against hepatocellular carcinoma (2021 · European Journal of Pharmacology · 被引 26)
• Radiosensitizing effect of gold nanoparticle loaded with small interfering RNA-SP1 on lung cancer (2021 · Translational Oncology · 被引 22)
• The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses (2023 · Biomarker Research · 被引 17)
• Tricetin attenuates atherosclerosis by suppressing macrophage ferroptosis via activation of the NRF2 pathway (2024 · International Immunopharmacology · 被引 15)